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Introduction {#sec1}
============

Cell migration plays a key role in a wide variety of biological phenomena that take place both during embryogenesis and in the adult organism. During embryonic development, there are numerous cases where organ or tissue formation depends upon the migration of primordial cells over large distances. Cell migration is also essential for immune cells to monitor the body and for epithelial cells to heal a wound. This fascinating behavior, which involves a large variety of intricately coordinated and controlled processes in normal cells, becomes destructive and damaging when acquired by cancerous cells. Hence, a better understanding of the molecular mechanisms underlying cell migration would not only further our comprehension about embryogenesis but also help us to understand, or even treat, cancer.

Cellular migration is the coordinated movement of cells over a substratum ([@bib19]). The substratum, depending on the cellular context, can be either the extracellular matrix (ECM) or the surface of other cells. Among the different ECM components, laminins have been shown to play a key role in the migration of several embryonic cell populations in different species ([@bib3]). During embryonic development, cells have been proposed to migrate on laminins found in the interstitial spaces and/or the basement membrane (BM) surrounding different tissues. However, experiments in cell culture have suggested that both exogenous and endogenous laminins may contribute to cell migration. This is the case for a variety of tumor cells, including melanomas and gliomas. Thus, in addition to migrating on laminins present in the BM of target tissues, tumor cells might also migrate on laminins produced by themselves ([@bib20], [@bib23], [@bib33]). Strikingly, the use of produced laminins during cell migration has not been demonstrated in embryos or adults.

*Drosophila* embryonic hemocytes are an ideal system to study the role of secreted laminins on cell migration. They are major producers of ECM components and perform a stereotyped migration through the embryo. They derive from the head mesoderm, and the majority become migratory and differentiate into macrophages ([@bib26]). At the end of stage 10, embryonic hemocytes initiate their migration throughout the embryo following three major routes, toward the tail, beneath the amnioserosa, and along the ventral nerve cord (VNC) ([@bib43]). Hemocyte migration along the VNC is required for proper ECM deposition around this tissue ([@bib34]) and its correct development ([@bib12]). Our preliminary analysis of the role of laminins during embryogenesis has shown that hemocytes fail to migrate along the VNC in laminin mutant embryos ([@bib44]). Thus, as ECM deposition around the VNC requires hemocyte migration and hemocytes need ECM components to move along this path, it is tempting to speculate that hemocytes deposit their own ECM to migrate. If this were the case, it would imply that embryonic migratory cells could behave in an analogous manner to tumor cells in their ability to use ECM component in an autocrine function for their migration. Here, we sought to investigate this by analyzing the role of laminin secretion during embryonic hemocyte migration.

Laminins are trimeric glycoproteins formed from three distinct subunits: α, β, and γ. Members of the laminin family are highly conserved. While in humans there are 15 different laminin trimers, *Drosophila* only contains two, which possess different α subunits, encoded by the genes wing blister and LanA, but share the same β and γ subunits, encoded by the genes LanB1 and LanB2, respectively. Isolation of LanB1 and LanB2 mutations in *Drosophila* has allowed the analyses of the effects of a complete loss of laminin function during embryogenesis ([@bib44], [@bib46]). As mentioned above, our initial analysis on laminin function in hemocyte development has shown that their migration along the VNC is compromised in lanB1 mutant embryos ([@bib44]). Furthermore, integrins, major laminin receptors, are also required for proper hemocyte migration in the *Drosophila* embryo ([@bib7]).

By combining live imaging with transplantation experiments and quantification analysis, we show that laminins are required for all steps of hemocyte migration throughout the embryo. We further demonstrate that autocrine-produced laminin enhance hemocyte migration by regulating lamellipodia dynamics and stability. Finally, our results uncover a function for the Rab8 RabGTPase in hemocyte migration, as Rab8 is required for proper laminin secretion and lamellipodia dynamics. Based on these results, we propose a model in which autocrine laminin deposition by hemocytes, regulated by Rab8, would reinforce directionally persistent and effective migration by stabilizing protrusions and strengthening otherwise transient adhesion states.

Results {#sec2}
=======

Laminins Regulate Hemocyte Migration over the VNC {#sec2.1}
-------------------------------------------------

Migrating hemocytes produce both laminins and collagens ([@bib31], [@bib32], [@bib48]). In a preliminary analysis of the role of laminins during *Drosophila* embryogenesis, we showed that hemocytes within embryos homozygous for a deficiency that removes the *LanB1* gene, hereafter referred as *LanB1* embryos, failed to migrate along the VNC. Quantification of the migration phenotype ([Figure S1](#mmc1){ref-type="supplementary-material"}) showed that while most wild-type embryos show no defect (83.3%, n = 48; [Figure S1](#mmc1){ref-type="supplementary-material"}), hemocyte migration was disrupted in 98.3% of *LanB1* embryos (n = 52; [Figure S1](#mmc1){ref-type="supplementary-material"}). To investigate in greater detail the role of laminins in hemocyte migration, we performed live imaging of embryos expressing UAS-GFPMoesin within hemocytes, using the *srpH*Gal4 driver (*srpH* \> GFPMoe; [@bib47]).

In wild-type embryos, hemocyte migration occurs in several phases ([@bib4], [@bib6], [@bib43]). Around stage 10, one group of hemocytes enter into the posterior end of the germband, surround the hindgut, and migrate to the posterior end of the developing VNC. We found that hemocytes from *LanB1* embryos (n = 33) surrounded the hindgut at a slower speed (0.54 ± 0.08 μm/min) than hemocytes from control embryos (n = 31, 1.7 ± 0.15 μm/min; [Figures 1](#fig1){ref-type="fig"}A--1G; [Movie S1](#mmc2){ref-type="supplementary-material"}). In the next phase of migration (stage 12), hemocytes from the anterior and posterior ends of the embryo move toward one another along both sides of the VNC ([@bib4], [@bib6], [@bib43]). Thus, by stage 13, hemocytes form a single band covering the entire VNC immediately beneath the epidermis ([Movie S2](#mmc3){ref-type="supplementary-material"}). In contrast, we found that in 98.3% of stage 13 *LanB1* embryos, hemocytes do not cover completely the VNC ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Our *in vivo* analysis revealed that hemocytes from *LanB1* embryos (n = 30) moved on both sides of the VNC at a slower speed than hemocytes from control embryos (n = 32), although migration was more affected on the ventral (1.73 ± 0.11 μm/min versus 3.06 ± 0.12 μm/min) than on the dorsal side (2.65 ± 0.14 μm/min versus 2.97 ± 0.07 μm/min; see below; [Figures 1](#fig1){ref-type="fig"}H and 1I; [Movie S2](#mmc3){ref-type="supplementary-material"}).Figure 1Laminins Are Required for Proper Hemocyte Migration around the Hindgut and Over the VNC and for Lamellipodia Dynamics and Persistence(A--F) Stills taken from live imaging of GFPMoe-expressing hemocytes migrating around the hindgut in control (A--C) and *LanB1* mutant embryos (D--F).(G) Tracking individual hemocytes reveals a significant decrease in the velocity of hemocytes from *LanB1* mutant embryos (p \< 0.001).(H and I) Graph showing a significant decrease in the velocity of hemocytes from *LanB1* embryos compared to control on both the (H) ventral (p \< 0.0001) and (I) dorsal sides of the VNC (p \< 0.01).(I and J) Hemocytes from control (I) and *LanB1* (J) embryos.(K and L) Graphs showing the lamellipodial area of (K) control (n = 6) and (L) *LanB1* (n = 7) hemocytes measured at 30-s intervals over a 30-min time period.(M and N) Average lamellipodial area (M) and lamellipodial area change (N) per hemocyte from control and *LanB1* embryos (n = 6 and 7 hemocytes from 3 different embryos per genotype, respectively).(O and P) Radial diagrams illustrating lamellipodia distribution in control (O) and *LanB1* embryos (P).Scale bars represent 50 μm (A--F) and 20 μm (I and J).

We have previously shown that hemocytes fail to progress along the midline in integrin mutant embryos. This was partially due to a failure in the separation of the VNC from the overlying epithelium. We thus proposed that the role of integrins in the VNC was to regulate proper assembly of ECM components, which in turn could be required for a correct separation of the VNC ([@bib7]). Indeed, using dye injections ([@bib12]), we found that in contrast to stage 15 control embryos, in which the dye permeates along the length of the embryo ([Figure S2](#mmc1){ref-type="supplementary-material"}A; n = 17), dye spreading in *LanB1* embryos is restricted, indicating areas where the epithelium failed to detach from the VNC ([Figure S2](#mmc1){ref-type="supplementary-material"}B; n = 15). This could explain why migration speed was more affected on the ventral side than on the dorsal side in *LanB1* embryos compared to controls ([Figures 1](#fig1){ref-type="fig"}H and 1I).

Together, these results reveal hemocyte specific and environmental requirements for laminins during hemocyte migration.

Hemocytes Require Laminins for Lateral, Random, and Inflammatory Migrations {#sec2.2}
---------------------------------------------------------------------------

At stage 13, hemocytes from wild-type embryos undergo a segmented and highly directional lateral migration away from the ventral midline, leading to the formation of three rows of hemocytes covering the ventral side of the VNC ([Figure S3](#mmc1){ref-type="supplementary-material"}A; [Movie S3](#mmc4){ref-type="supplementary-material"}) ([@bib47]). We found there was a reduction in the number and speed of hemocytes migrating laterally in *LanB1* embryos (n = 72 and n = 30, respectively) compared to controls (n = 102 and n = 28, respectively) ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3D; [Movie S3](#mmc4){ref-type="supplementary-material"}).

At stage 15, wild-type hemocytes move locally in a random manner and undergo contact repulsion, which is key to maintain their even distribution ([Movie S4](#mmc5){ref-type="supplementary-material"}; [@bib40], [@bib47]). Hemocytes from *LanB1* embryos (n = 42) moved locally at a slightly but significantly slower speed (2.31 ± 0.09 μm/min) than control cells (n = 41) (2.76 ± 0.15 μm/min) ([Figures S3](#mmc1){ref-type="supplementary-material"}E--S3G; [Movie S4](#mmc5){ref-type="supplementary-material"}). In addition, while the average time that control hemocytes remained in contact was ∼5 min (n = 72), hemocytes from *LanB1* embryos (n = 58) remained in contact for prolonged periods (7.5 min) ([Figures S3](#mmc1){ref-type="supplementary-material"}H--S3J).

Finally, we analyzed laminin requirements in hemocytes during their inflammatory migration to wounds. To do this, we used laser ablation to create epithelial wounds in the anterior trunk of the embryo, in areas occupied with hemocytes. While hemocytes from *LanB1* embryos were competent to respond to an inflammatory cue ([Figure S4](#mmc1){ref-type="supplementary-material"}), there was a significant reduction in the speed and number of hemocytes recruited to wounds at the early stages of this inflammatory migration ([Figure S4](#mmc1){ref-type="supplementary-material"}C). Together, these results show that laminins are required for both directed and random migrations.

Laminins Regulate Proper Lamellipodia Formation and Dynamics {#sec2.3}
------------------------------------------------------------

We next decided to test whether alterations in the migratory behavior of *LanB1* hemocytes could be the result of aberrant lamellipodia dynamics. To this end, we analyzed lamellipodia area over time in hemocytes from control and *LanB1* embryos during the phase of random migration. Our results revealed that both lamellipodia dynamics and area were affected in *LanB1* embryos ([Figure 1](#fig1){ref-type="fig"}I--1N). The fact that the lamellipodia area was significantly reduced (30%) in hemocytes from mutant embryos (353 ± 6 μm^2^, n = 49) compared to controls (506 ± 5 μm^2^, n = 47) ([Figure 1](#fig1){ref-type="fig"}I--1N) suggests that laminins might be required for the cell-adhesion events that take place during cell migration.

Formation and stabilization of lamellipodia plays a critical role in achieving directionally persistent migration in cell culture (reviewed in [@bib36]). Our *in vivo* analysis reveals that migrating hemocytes from control embryos seem to sustain over time a relatively constant orientation of lamellipodia protrusion in the direction of the movement. To quantify this, we analyzed lamellipodia distribution over time during random migration ([Movie S4](#mmc5){ref-type="supplementary-material"}). We found that hemocytes from control embryos extend and maintain lamellipodia protrusion preferentially in the direction of migration ([Figure 1](#fig1){ref-type="fig"}O). This persistence was reduced in hemocytes from *LanB1* embryos ([Figure 1](#fig1){ref-type="fig"}P).

Altogether, these results strongly suggest that laminins support directional migration by regulating lamellipodia formation, dynamics, and persistence.

Hemocytes Provide Laminins in an Autocrine Fashion for Their Migration {#sec2.4}
----------------------------------------------------------------------

During *Drosophila* embryogenesis, several cell populations produce laminins, including hemocytes, fat body, and some neuronal cells ([@bib25], [@bib32]). Hence, there are multiple sources of laminins hemocytes could use as a substrate during their migration throughout the embryo, including an autonomous one produced by hemocytes themselves, an exogenous one, or both. To test the contribution of the laminins produced autonomously by hemocytes, we used two strategies. First, we specifically expressed RNAi constructs against the *LanB1* or *LanB2* genes in either hemocytes (n = 108; [Figures S5](#mmc1){ref-type="supplementary-material"}B and S5D; data not shown) or in glia and neural progenitor cells. We found that while the expression of *LanB1* or *LanB2* RNAis in hemocytes resulted in migration defects similar to those observed in *LanB1* embryos, their expression in neuronal cells only caused subtle defects ([Figures S5](#mmc1){ref-type="supplementary-material"}C and S5D). Second, we developed a method for transplanting hemocytes from the head mesoderm of donor embryos into the VNC of host embryos. To distinguish donor from host hemocytes, donors were labeled using mChMoe while hosts were marked with GFPMoe (see [Experimental Procedures](#sec4){ref-type="sec"}). We performed a number of fluorescently labeled hemocyte transplantations, including control hemocytes into control embryos (n = 10), control hemocytes into *LanB1* embryos (n = 10), and *LanB1* hemocytes into control embryos (n = 12). We then analyzed their migration *in vivo* and quantified lamellipodia areas of the different hemocyte types ([Figure 2](#fig2){ref-type="fig"}; [Movies S5](#mmc6){ref-type="supplementary-material"}, [S6](#mmc7){ref-type="supplementary-material"}, and [S7](#mmc8){ref-type="supplementary-material"}). We found that the migration speed of control hemocytes transplanted into control embryos (2.44 ± 0.17 μm/min) was similar to that of control hemocytes transplanted into *LanB1* embryos (2.37 ± 0.08 μm/min). However, the speed of *LanB1* hemocytes transplanted into control embryos was significantly slower (1.52 ± 0.08 μm/min; [Figure 2](#fig2){ref-type="fig"}D). Furthermore, we found that the lamellipodia area of hemocytes was 27.6% smaller in *LanB1* embryos transplanted in control embryos than in hemocytes from control embryos transplanted in control or *LanB1* embryos ([Figures 2](#fig2){ref-type="fig"}E--2H).Figure 2Hemocytes Provide Autocrine Laminins as a Substrate for Their Movement(A--C) Still images taken from live imaging of transplanted hemocytes from (A) control embryos (red) into control embryos (green), (B) *LanB1* embryos (red) into control embryos (green), and (C) control embryos (red) into *LanB1* embryos (green).(A′--C′) Tracking analysis of (A)--(C), respectively.(D) Quantification of hemocyte migration speed in the transplanted embryos of the indicated genotypes.(E--G) Hemocytes from control embryos in control (E) and LanB1 mutant embryos (G) and hemocytes from *LanB1* in control embryos (F).(H) Graph showing lamellipodia area of transplanted hemocytes relative to controls (hemocytes from control embryos transplanted in control embryos).Scale bars represent 30 μm (A--C) and 20 μm (E--G).

Overall, these results implicate autocrine-produced laminin in the regulation of hemocyte lamellipodia dynamics and thus in the control of their directional migration.

Laminins Assemble in Different Patterns during Embryogenesis {#sec2.5}
------------------------------------------------------------

Cell culture experiments have shown that laminins can be assembled in diverse patterns ([@bib22]). Furthermore, it has been speculated that these different laminin patterns might specify cell behaviors (reviewed in [@bib17], [@bib39]).

In stage 11 and 12 *Drosophila* embryos, laminins have been detected in the mesodermal layer, cephalic mesoderm, hemocytes, and fat body ([@bib25], [@bib32]). Upon germband retraction, laminins were also found as part of the dorsal BM overlying the VNC ([@bib32]). These studies were performed using antibodies against the LanB1 and LanB2 subunits and conventional light microscopy in fixed tissue. Although informative, these studies did not allow the detection of putative specific patterns in which laminins might assemble *in vivo*. To tackle this issue, we used a fosmid containing a GFP-tagged *LanB1* gene ([@bib38]) and high-resolution methods for *in vivo* imaging (see [Experimental Procedures](#sec4){ref-type="sec"}). Our results show that hemocytes undergoing either developmental or inflammatory migrations contain laminin-rich punctae ([Figure 3](#fig3){ref-type="fig"}A; [Movie S8](#mmc9){ref-type="supplementary-material"}). In addition, laminin is also found around hemocytes assembled in track-like arrays ([Figure 3](#fig3){ref-type="fig"}B; [Movie S9](#mmc10){ref-type="supplementary-material"}). To determine whether these trails of laminins around migrating hemocytes are deposited by hemocytes themselves, we examined fluorescence recovery after photobleaching (FRAP) of LanB1-GFP in a region containing hemocytes undergoing lateral migration ([Figures 3](#fig3){ref-type="fig"}D--3D″; [Movie S10](#mmc11){ref-type="supplementary-material"}). Deposition of LanB1-GFP was detected around hemocytes in the photobleached area 2 min after bleaching ([Figures 3](#fig3){ref-type="fig"}D and 3E; [Movie S10](#mmc11){ref-type="supplementary-material"}). Interestingly, LanB1-GFP deposition in trails was particularly prominent around extended lamellipodia ([Movie S10](#mmc11){ref-type="supplementary-material"}, arrows). These results suggest that hemocytes assemble trails of laminins that could be used as a substratum over which they move. Next, we analyzed in more detail LanB1-GFP distribution around the VNC by performing high-resolution analysis and 3D imaging of live dissected stage 14 embryos (see [Experimental Procedures](#sec4){ref-type="sec"}). We found that LanB1-GFP was organized as a fibrillar mesh surrounding the VNC ([Figure 3](#fig3){ref-type="fig"}C; [Movie S11](#mmc12){ref-type="supplementary-material"}).Figure 3LanB1-GFP Distribution around Hemocytes and the VNC(A) Dorsal view of a fixed stage 10 control embryo expressing a LanB1-GFP fosmid stained with anti-GFP (green) and anti-Srp (red) antibodies. LanB1-GFP can be found around migrating hemocytes (arrowhead).(B--D) Still images taken from live LanB1-GFP; srpH \> mChMoe embryos. Hemocytes entering the tail in stage 10 embryos (B). LanB1-GFP can be found in track-like arrays around hemocytes (arrowhead). Dorsal view of a stage 14 embryo showing LanB1-GFP decorating the BM surrounding the VNC (C). Representative images of hemocytes over the VNC of a stage 14 embryo during a FRAP experiment (D).Scale bars represent 20 μm (A), 15 μm (B and C), and 10 μm (D).

In sum, these results show that laminins can be assembled and/or deposited in different patterns throughout embryogenesis.

Rab8 Is Required for Proper Hemocyte Migration {#sec2.6}
----------------------------------------------

The Rab family of GTPases, and in particular Rab8 and Rab10, have been shown to regulate secretion of ECM components. In addition, cell culture studies have revealed important functions for Rab8 in regulating cell migration ([@bib18]). Thus, we next tested whether these Rabs play any role during hemocyte migration. First, we investigated if they were expressed in hemocytes as they migrate. To this end, we used transgenic flies in which the coding sequence for these Rabs has been N-terminally tagged, by homologous recombination, with YFP, hereafter referred as Rab8YFP and Rab10YFP ([@bib10]). We observed that while Rab8YFP was found at high levels in cytoplasmic puncta in migrating hemocytes, Rab10YFP was barely detected ([Figures 4](#fig4){ref-type="fig"}A and 4B). Furthermore, as it happens in *Drosophila* follicle ([@bib9]) and embryonic epithelial cells ([@bib29]), a proportion of Rab8YFP positive puncta co-express the *cis*-Golgi marker GM130 ([Movie S12](#mmc13){ref-type="supplementary-material"}), consistent with the known role of Rab8 in regulating vesicle trafficking from the Golgi to the plasma membrane ([@bib45]).Figure 4The RabGTPase Rab8 Is Required for Proper Hemocyte Migration(A and B) Ventral view of fixed stage 13 embryos expressing mChMoe in hemocytes (srpH \> mChMoe) and Rab8YFP (A) or Rab10YFP (B) stained with anti-RFP (red) and anti-GFP (green) antibodies.(C--F) Lateral view of fixed stage 13 embryos expressing UAS-mChMoe and UAS-Rab8^DN^ (C), UAS-Rab10^DN^ (D), or a UAS-RNAi (F) against *stratum* under the control of the *srpH-Gal4* driver and staining with an anti-RFP antibody. Stage 13 *crag* mutant embryo expressing mChMoe in hemocytes (E).(G) Quantification of hemocyte migration phenotype over the VNC in embryos of the indicated genotype.(H) Quantification of migration speed in hemocytes expressing Rab8^DN^ compared to hemocytes from control and *LanB1* embryos during random migration. The statistical significance of differences was assessed with a t test; ^∗∗∗^p \< 0.0001 and ^∗∗^p \< 0.005.Scale bars represent 50 μm.

Accordingly, expression of a dominant-negative form of Rab8 (Rab8^DN^; [Figure 4](#fig4){ref-type="fig"}C; n = 110) ([@bib49]), or an RNAi against its recently identified GEF *stratum* ([Figure 4](#fig4){ref-type="fig"}F; n = 92) ([@bib9]), specifically in hemocytes impaired their migration ([Figure 4](#fig4){ref-type="fig"}G). *In vivo* analysis of random migration revealed that similar to hemocytes from LanB1 embryos, hemocytes expressing Rab8^DN^ move at a slower speed (2.19 ± 0.08 μm/min) than controls (2.75 ± 0.15 μm/min; [Figure 4](#fig4){ref-type="fig"}H; [Movie S13](#mmc14){ref-type="supplementary-material"}). In contrast, hemocytes expressing a dominant-negative form of Rab10 (Rab10^DN^; n = 68) ([@bib49]) or mutant for *crag* (n = 50) showed minor migratory defects ([Figures 4](#fig4){ref-type="fig"}D, 4E, and 4G).

In an attempt to test whether these Rabs were required for proper laminin secretion, we quantified LanB1-GFP levels around the VNC in stage 13 embryos expressing Rab8^DN^ specifically in hemocytes and compared them to those found in control embryos. Because hemocyte migration is impaired in the experimental condition, there were areas of the VNC packed with hemocytes where LanB1-GFP levels could be higher simply due to the increased number of hemocytes. To avoid this, we only analyzed areas with similar number of hemocytes in control and experimental embryos ([Figures 5](#fig5){ref-type="fig"}A and 5B). We found that LanB1-GFP levels in the VNC were higher in experimental embryos than in control embryos (28.07 ± 3.80 versus 17.65 ± 2.71; [Figures 5](#fig5){ref-type="fig"}A--5C). In addition, high-resolution analysis and 3D imaging of hemocytes entering the tail revealed that levels of laminins outside of hemocytes were higher and more uniformly distributed around Rab8^DN^-expressing hemocytes compared to controls ([Movie S14](#mmc15){ref-type="supplementary-material"}; compare with [Movie S9](#mmc10){ref-type="supplementary-material"}).Figure 5Rab8 Regulates LanB1-GFP Secretion and Lamellipodia Dynamics(A) Lateral view of fixed stage 15 embryos expressing mChMoe in hemocytes (srpH \> mChMoe) and LanB1-GFP stained with anti-RFP (red) and anti-GFP (green) antibodies.(B) Role of Rab8 on regulating laminin secretion was assessed by co-expressing UAS-Rab8^DN^.(C) Quantification of LanB1-GFP intensity in the VNC of embryos expressing UAS-Rab8^DN^ in hemocytes.(D and E) Control (D) and Rab8^DN^-expressing (E) hemocytes.(F--I) Average lamellipodial area (F), lamellipodial area change (G), and radial diagrams illustrating the distribution of lamellipodia in control (H) and Rab8^DN^-expressing hemocytes (I).Scale bars represent 50 μm (A and B) and 20 μm (D and E).

We have shown here that proper lamellipodia formation and dynamics require laminins produced autonomously by hemocytes. As laminin levels and distribution are affected in Rab8^DN^-expressing hemocytes, we tested whether lamellipodia dynamics were altered in these mutant hemocytes. Indeed, we found that similar to the elimination of laminins, expression of Rab8^DN^ in hemocytes results in smaller (314.45 ± 6 μm^2^ versus 504 ± 7 μm^2^) and less stable and persistent lamellipodia ([Figures 5](#fig5){ref-type="fig"}D--5I).

Discussion {#sec3}
==========

Laminins are expressed in tumor-target tissues as well as in many tumor cells, including glioma, breast cancer, and malignant melanoma cells. This has led to the proposition that both exogenous and endogenous laminins may contribute to tumor dissemination ([@bib5], [@bib20], [@bib23], [@bib33]). Single-cell assays have shown that human keratinocytes also deposit laminin 5 to promote persistent and linear migration in the absence of a chemotactic gradient ([@bib14]). Here, we show that *Drosophila* embryonic hemocytes use both exogenous and endogenous laminins for their migration over the VNC. Furthermore, our transplantation experiments and our results showing that migration defects are stronger when laminins are reduced in hemocytes than when they are decreased in the VNC demonstrate that endogenous laminins are more relevant to hemocyte migration than exogenous ones. Our discovery that laminins regulate lamellipodia stability and dynamics suggests that by using endogenous laminins, hemocytes could stabilize cellular protrusions locally, thus reinforcing directional migration. In fact, culture assays and xenograft of fibrosarcoma HT1080 cells have shown that fibronectin is endocytosed and re-secreted from a late endosomal/lysosomal compartment to provide an autocrine ECM substrate to enhance directional migration ([@bib41], [@bib42]). Local concentrations of ECM molecules via secretion may facilitate integrin clustering and/or activity, leading to accelerated migration. In addition, many ECM components have binding sites for growth factors ([@bib24]). Thus, local levels of ECM molecules could also allow high confined concentrations of growth factors, which in turn would enhance their activity.

The mechanisms underlying laminin secretion remain largely unknown. Recent experiments in *Drosophila* have shown that downregulation of Rab10 and its GEF Crag results in aberrant secretion of BM components, including laminins, at the apical side of follicle cells ([@bib8], [@bib28]). Here, we find that Rab8 is required in migrating embryonic hemocytes for proper laminin secretion and migration. Thus, we propose that Rab8 might serve a function in hemocytes similar to that perform by Rab10 in epithelial follicle cells (i.e., the control of proper secretion of ECM components). This in the context of epithelial cells is essential for correct morphogenesis while in the context of migrating cells is key for efficient and directional movement. In fact, cell culture experiments have demonstrated that appropriate levels of ECM ligands are essential for correct cell movement, with a maximal velocity at middle levels of substrate and a block in migration at higher substrate concentrations ([@bib35]). Our results also show that, as is the case in cell culture experiments ([@bib18]), Rab8 regulates lamellipodia dynamics and stability during developmental cell migration. Because laminins are also required for proper lamellipodia dynamics, the role of Rab8 in regulating lamellipodia dynamics could be in part mediated via its ability to control proper laminin secretion. However, besides a role in regulating secretion of ECM proteins, the Rab GTPases have also been involved in controlling membrane trafficking routes as well as endocytosis and trafficking of growth factor receptors, integrins, and RhoGTPases during cell migration ([@bib2], [@bib37]). In the future, it will be interesting to determine the contribution of the different putative roles of Rab8 to cell migration during development.

Cell culture experiments have shown that despite their relatively uniform structure, laminins are deposited into diverse patterns in the ECM depending on the cell type ([@bib22]). Furthermore, it has been proposed that differences in laminin patterns might be essential in specifying cellular behaviors. Keratinocytes provide an interesting example of how laminin deposition patterns might affect matrix function. In non-migratory human keratinocytes, laminin-332 appears in a rosette-like pattern, whereas actively migrating keratinocytes in culture assemble trails of laminin-332 over which they move ([@bib17], [@bib39]). Lung alveolar epithelial cells organize a laminin-331 matrix into fibrils, which is used to transmit mechanosignals in the form of stretch ([@bib21]). Similarly, a polarized fibrillar BM has been shown to constrain tissue shape during egg chamber elongation in *Drosophila* ([@bib15], [@bib16]). Our *in vivo* analysis of laminin expression reveals that laminins are organized at least in two different patterns in the *Drosophila* embryo: in track-like arrays surrounding migrating hemocytes and, at the end of embryogenesis, in a fibrillar mesh surrounding the VNC. We would like to propose that these distinct ways in which laminins are assembled and/or deposited might serve distinct laminin functions. Thus, while the role of laminins deposited by hemocytes might be to promote a migratory behavior, laminins deposited in the BM of the VNC could be required to transmit forces necessary for VNC condensation. The former is supported by our results showing that reducing the levels of laminins specifically in hemocytes affects their migration. The latter is supported by results showing that reducing ECM components around the VNC, by preventing hemocyte migration, leads to VNC condensation defects ([@bib34]) and by our own results showing that VNC condensation is affected in *LanB1* embryos ([@bib44]). In the future, it will be interesting to assess to what extent differences in laminin assembly and/or deposition specify cell behaviors and to dissect the mechanisms underlying laminin-deposition and/or assembly patterns.

Laminins have been widely reported to promote cancer cell migration and tumor progression. They have been recently termed as "oncolaminins" because (1) they are expressed in tumor cells correlating with malignancy, (2) their expression is positively regulated by oncogenic transcription factors, and (3) they interact with integrins, which was previously implicated in tumor invasion and progression. Accordingly, human antibodies to specific domains of the laminin proteins inhibit tumor growth and metastasis of melanoma ([@bib30]). In addition, as we have shown here for embryonic hemocytes, tumor cell-produced laminins contribute to tumor migration and dissemination ([@bib5], [@bib20], [@bib23], [@bib33]). Thus, we can exploit the advantages offered by *Drosophila* embryonic hemocytes to provide novel insights into the molecular and cellular mechanism by which laminins control robust migratory responses both during development and in physiological and pathological conditions, such as wound healing and cancer.

Experimental Procedures {#sec4}
=======================

*Drosophila* Strains {#sec4.1}
--------------------

Flies were raised at 25°C. Embryos were collected from laying cages kept overnight at 25°C. For RNAi experiments, laying cages were kept overnight at 29°C. The following stocks were used: *w; LanB1*^*Def*^*/CyO* ([@bib44]), *ywcrag*^*A*^{neoFRT}19A/FM7c (Bloomington *Drosophila* Stock Center), srp-HemoGAL4 ([@bib4]), *elav*-*GAL4* ([@bib1]), UASp-YFP.Rab8.T22N and UASp-YFP.Rab10.T23N ([@bib49]), Rab8^YFP^ and Rab10^YFP^ ([@bib10]), UAS-RNAi LanB2 and UAS-RNAi LanB1(Vienna *Drosophila* Resource Center \[VDRC\]), and UAS-stratum (Bloomington).

For time-lapse imaging, *serpent-HemoGAL4* (*srpH*) ([@bib4]) was used to drive hemocyte-specific expression of the UAS constructs UAS-GFP-Moesin ([@bib11]) and UAS-mCherry-Moesin (a gift from Paul Martin, University of Bristol).

Histochemistry {#sec4.2}
--------------

Antibody staining of embryos was performed using standard procedures. We used the following primary antibodies: rat anti-RFP (1:200, Chromotek), rabbit anti-LanB1 (1:500, Abcam), chicken anti-GFP (1:500, Abcam), rabbit anti-Srp (1:5,000; Riechman et al., 1998), mouse anti-CD2 (1:7, DHSB, Iowa), and rabbit anti-GM130 (1:200, Abcam). Fluorescence-conjugated antibodies used were Alexa Fluor 488, Alex Fluor 568, Alexa Fluor 555 (Life Technologies). For non-fluorescent staining, embryos were incubated in biotinylated secondary antibodies followed by incubation with Elite ABC complex (Vector Laboratories) and revealed with 3,3′-diaminobenzidine (DAB; Gibco). Images were collected with a Leica SP2-AOBS, a Leica SP5-MP-AOBS confocal microscope, and a Zeiss LSM 880.

For live imaging of LanB1-GFP around the VNC, we used a protocol based on the one described by [@bib27]. In summary, dechorionated embryos were placed dorsal side down on a small rectangular slab of agar. The embryos were then transferred to a slide covered with a double-sided sticky tape. 1× PBS was immediately added over the embryos, and a cut was made along the dorsal midline using an insect pin/needle. Then, the flaps of the body wall were gently pasted down onto the slide, avoiding stretching or removing material from the surface. PBS was then removed and replaced with fluorescent mounting medium (Vectashield, Vector Laboratories), and live imaging was performed.

Image Processing and Analysis {#sec4.3}
-----------------------------

Cell tracking and cell area measurements were performed using ImageJ (NIH) and Imaris (Bitplane). Co-localization analysis was done using Imaris. Integrated intensity of Rab8YFP and GM130 were quantified for manually selected hemocytes. The background value taken from cell-free regions was subtracted from all data series. Measurements of lamellipodia distribution were done manually as described previously ([@bib13]). In summary, a line was drawn from the center of the hemocyte body to the tip of the lamellipodia. To analyze lamellipodia orientation, the angle of this line relative to the x axis was calculated. Graphs and statistical analysis was carried out using Prism for Mac (GraphPad). Unless otherwise stated, hemocyte migratory behavior was analyzed using images acquired from five embryos of each genotype.

Time-Lapse Recording, Wounding, and Dextran Injections {#sec4.4}
------------------------------------------------------

Embryos were prepared and mounted as previously described ([@bib40], [@bib47]). Imaging for all steps of hemocyte migration, including migration into the tail, along the VNC, lateral and random, as well as that for contact repulsion of stage 15 embryos, wounding assays, and dextran injections, was performed as previously described ([@bib7]). All live imaging was conducted on a Leica SP5 MP-AOBS confocal microscope, except for wounding assays and dextran injections, which were imaged on a spinning disc confocal microscope (Ultraview; PerkinElmer; [@bib7]).

Transplantation Assay {#sec4.5}
---------------------

Embryos were dechorionated as per live imaging. Donor and receptor embryos were mounted in two parallel lines facing each other over a glass slide covered with a double-sided sticky tape. They were dried for 1 min using silica gel and then covered with a drop of Voltalef oil (10S). Using a Narishige micromanipulator, hemocytes from the head mesoderm of donor embryos were sucked and released into the VNC of receptor embryos. To differentiate donor from host hemocytes, donors were labeled using mChMoe, whereas hosts were marked with GFPMoe. After this step, embryos were kept at 25°C for 3 hr to allow healing of the wound generated during the transplantation procedure. To preserve a certain degree of humidity during this time, embryos were placed in a petri dish containing a roll of wet tissue. After this step, embryos were imaged live as described previously ([@bib40], [@bib47]).
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Supplemental Information {#app2}
========================

Document S1. Figures S1--S5Movie S1. Early Phase of Hemocyte Migration into the Tail and around the Hindgut in Control and *LanB1* EmbryosDorsal view of stage 10 embryos showing live imaging of GFPMoe expressing hemocytes migrating into the tail and around the hindgut. Confocal stills were acquired at 60 seconds time intervals and the movie displayed at 15 frames/second for 160 minutes.Movie S2. Hemocyte Migration over the VNC in Control and *LanB1* EmbryosLateral view of stage 12 embryos showing live imaging of GFPMoe expressing hemocytes migrating over both the dorsal and ventral sides of the. Confocal stills were acquired at 60 seconds time intervals and the movie displayed at 10 frames/second for 120 minutes.Movie S3. Lateral Hemocyte Migration in Control and *LanB1* EmbryosVentral view of stage 13 embryos showing live imaging of GFPMoe expressing hemocytes migrating laterally. Confocal stills were acquired at 60 seconds time intervals and the movie displayed at 10 frames/second for 70 minutes.Movie S4. Random Hemocyte Migration in Control and *LanB1* EmbryosVentral view of stage 15 embryos showing live imaging of GFPMoe expressing hemocytes migrating randomly. Confocal stills were acquired at 30 seconds time intervals and the movie displayed at 10 frames/second for 30 minutes.Movie S5. Hemocytes from Control Embryos Transplanted into Control EmbryosLive imaging of mChMoe expressing hemocytes from control embryos transplanted into control embryos that express GFPMoe in hemocytes. Confocal stills were acquired at 5 minutes time intervals and the movie displayed at 6 frames/second for 88 minutes.Movie S6. Hemocytes from Control Embryos Transplanted into *LanB1* EmbryosLive imaging of mChMoe expressing hemocytes from control embryos transplanted into LanB1embryos that express GFPMoe in hemocytes. Confocal stills were acquired at 4 minutes time intervals and the movie displayed at 6 frames/second for 92 minutes.Movie S7. Hemocytes from *LanB1* Embryos Transplanted into Control EmbryosLive imaging of mChMoe expressing hemocytes from *LanB1* embryos transplanted into control embryos that express GFPMoe in hemocytes. Confocal stills were acquired at 7 minutes time intervals and the movie displayed at 6 frames/second for 98 minutes.Movie S8. Dynamic Expression of LanB1-GFP in Hemocytes Migrating Randomly and toward a WoundVentral view of stage 15 embryos showing live imaging of mChMoe expressing hemocytes migrating randomly (left panel) and to a wound (right panel) in embryos containing a LanB1-GFP tagged gene. Confocal stills were acquired at 60 seconds time intervals and the movie displayed at 10 frames/second for 60 minutes.Movie S9. 3D Reconstruction of mChMoe-Expressing Hemocytes in an Embryo Containing a LanB1-GFP-Tagged Gene Stained with Anti-GFP and Anti-RFP AntibodiesThe animation shows the distribution of LanB1-GFP around hemocytes during their migration from the hindgut into the VNC in a stage 12 embryo.Movie S10. FRAP Analysis of LanB1-GFP in an Embryo Expressing mChMoe Specifically in HemocytesLive imaging of LanB1-GFP recovery after photobleaching an area of an embryo containing mChMoe expressing hemocytes migrating laterally.Movie S11. 3D Reconstruction of LanB1-GFP Deposited around the VNC in an Embryo Expressing mChMoe Specifically in HemocytesThe animation shows the distribution of LanB1-GFP around the VNC in a stage 14 embryo fillet.Movie S12. Expression of Rab8YFP and a *cis*-Golgi Marker within HemocytesThe animation shows localization of Rab8YFP and the cis-Golgi marker GM103 in hemocytes.Movie S13. Rab8^DN^-Expressing Hemocytes Migrating RandomlyVentral view of stage 15 embryos showing live imaging of GFPMoe and Rab8^DN^ expressing hemocytes migrating randomly. Confocal stills were acquired at 60 seconds time intervals and the movie displayed at 10 frames/second for 22 minutes.Movie S14. 3D Reconstruction of Hemocytes Expressing mChMoe and Rab8^DN^ in an Embryo Containing a LanB1-GFP-Tagged Gene Stained with Anti-GFP and Anti-RFP AntibodiesThe animation shows the distribution of LanB1-GFP around hemocytes expressing Rab8^DN^ and mChMoe during their migration from the hindgut into the VNC in a stage 12 embryo (dorsal view).Document S2. Article plus Supplemental Information
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